Welcome to the new Oncology Central – a note from the Editor
*Photo credit: Joanna Thomas (National Institute of Health)
I am delighted to the launch of our brand-new website, with the aim of delivering you a more intuitive and enhanced experience! We love the new look and feel of the site and I hope it will allow you navigate through Oncology Central’s extensive catalog of articles and multimedia content with increased ease.
The site provides a fully responsive experience, intelligently pulling the latest content from each subject area, making it easier and quicker for you to find the most popular pieces in your area of interest, with the ability to browse content based on disease or subject area. For example, on the disease area landing page you can find our ‘Top 10’ picks, view ‘Must Watch’ videos and use our carousel to navigate to the cancer type you want to read more about.
To start off, why not check out this round-up article, which highlights the biggest advancements in colorectal cancer or listen to this podcast that explores the TAILORx trial – one of the hottest talks presented at the Annual Meeting of the American Society of Clinical Oncology (ASCO; 1–5 June 2018, IL, USA).
I am also very excited to let you know about our latest Spotlight on tumor mutation burden, this 3 month feature draws on opinions from an international consortium of experts through peer-reviewed journal articles, interviews and much more. One of my content highlights from this feature is an opinion piece that provides a comprehensive view on tumor mutation burden and response to immunotherapy, highlighting the latest and most important studies. If you would like to find out more, you can view all our Spotlight content here.
As you can see, there’s a lot happening on the new Oncology Central and even more in the pipeline, which I look forward to sharing with you in the coming weeks! In the meantime, here are my personal top five content picks:
Our top oncology content of 2018 – a note from the Editor
PAN Cancer trial aims to produce a breath test to identify early-stage cancer
Triple-negative breast cancer: infographic
Scientific and regulatory challenges in development of CAR-T therapy for solid tumors
GioTag: results of real-world study of treatment sequencing in EGFR mutation-positive lung cancer
If you have any feedback or questions about the new site please do not hesitate to comment below or alternatively email your thoughts to me.
All the best,
Jade Parker
Editor, Oncology Central
Like what you see? Become a member of Oncology Central FREE of charge for full access to all features.